Cargando…
Pilot study of p62 DNA vaccine in dogs with mammary tumors
Our previous data demonstrated profound anti-tumor and anti-metastatic effects of p62 (sqstm1) DNA vaccine in rodents with various types of transplantable tumors. Testing anti-cancer medicine in dogs as an intermediary step of translational research program provides two major benefits. First, clinic...
Autores principales: | Gabai, Vladimir, Venanzi, Franco M., Bagashova, Elena, Rud, Oksana, Mariotti, Francesca, Vullo, Cecilia, Catone, Giuseppe, Sherman, Michael Y., Concetti, Antonio, Chursov, Andrey, Latanova, Anastasia, Shcherbinina, Vita, Shifrin, Victor, Shneider, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350343/ https://www.ncbi.nlm.nih.gov/pubmed/25296974 |
Ejemplares similares
-
Plasmid DNA-coding p62 as a bone effective anti-inflammatory/anabolic agent
por: Sabbieti, Maria Giovanna, et al.
Publicado: (2015) -
Broad-spectrum anti-tumor and anti-metastatic DNA vaccine based on p62-encoding vector
por: Venanzi, Franco, et al.
Publicado: (2013) -
p62-DNA-encoding plasmid reverts tumor grade, changes tumor stroma, and enhances anticancer immunity
por: Venanzi, Franco M., et al.
Publicado: (2019) -
P62 plasmid can alleviate diet-induced obesity and metabolic dysfunctions
por: Halenova, Tatiana, et al.
Publicado: (2017) -
Immunohistochemical Expression of p62 in Feline Mammary Carcinoma and Non-Neoplastic Mammary Tissue
por: Magi, Gian Enrico, et al.
Publicado: (2022)